Previous close | 12.75 |
Open | 12.72 |
Bid | 12.77 x 400 |
Ask | 12.81 x 400 |
Day's range | 12.66 - 12.89 |
52-week range | 8.87 - 18.70 |
Volume | |
Avg. volume | 2,227,339 |
Market cap | 5.384B |
Beta (5Y monthly) | 0.86 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
MURRAY, Utah, May 24, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 2024 Jefferies Global Healthcare Conference on Wednesday, June 5, 2024, at 10:30am ET. A live audio webcast of this presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay of the webc
MURRAY, Utah, May 08, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physician groups, today announced results for the three months ended March 31, 2024 and updated full year 2024 outlook. First Quarter 2024 Results: Revenue of $603.9 million, up $58.3 million or 10.7% compared to the same period last year.GAAP net loss
MURRAY, Utah, April 30, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its management team will present at the 2024 Bank of America Securities Health Care Conference on Thursday, May 16, 2024, at 11:00am ET. A live audio webcast of this presentation will be available on the Investor Relations section of R1’s website at r1rcm.com. A replay